Blog author by : invent

16 04-2012
Los Angeles Syndicate of Technology Announces that Portfolio Company, Sanguine BioSciences, has Received Approval to Serve Patients Diagnosed with Multiple Sclerosis, Alzheimer’s Disease, and Parkinso

SANTA MONICA, Calif., April 16, 2012 /PRNewswire/ — Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a publicly-traded venture fund and technology incubator, is pleased to announce that its portfolio company, Sanguine BioSciences, Inc. (“Sanguine”), has received approval from...

Read more...
10 04-2012
Los Angeles Syndicate of Technology Announces its Portfolio Company, Sanguine BioSciences, Inc. Makes Major Appointment to Scientific Advisory Board

SANTA MONICA, Calif., April 10, 2012 /PRNewswire/ — Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a publicly-traded venture fund and technology incubator, is pleased to announce that its portfolio company, Sanguine BioSciences, Inc. (“Sanguine”), has appointed Dr. Timothy...

Read more...
27 03-2012
Los Angeles Syndicate of Technology Announces Successful Launches of First Three Portfolio Companies

SANTA MONICA, Calif., March 27, 2012 /PRNewswire/ — Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a Business Development Company (BDC) that incubates early stage technology companies, has announced the successful launches of the first three portfolio companies built...

Read more...
08 12-2011
Los Angeles Syndicate of Technology to Present at the 4th Annual LD MICRO Growth Conference

SANTA MONICA, Calif., Dec. 8, 2011 /PRNewswire/ — Los Angeles Syndicate of Technology, Inc. (OTC: LAST), a Los Angeles-based venture capital firm that invests in consumer internet technology companies with the plan of going public on the new NASDAQ...

Read more...
24 08-2011
SC 13D – General statement of acquisition of beneficial ownership

Filed: 2011-08-24 AccNo: 0001010549-11-000938 Size: 38 KB Source: SEC Filings

Read more...
24 08-2011
SC 13D – General statement of acquisition of beneficial ownership

Filed: 2011-08-24 AccNo: 0001010549-11-000938 Size: 38 KB Source: SEC Filings

Read more...